NCT05650229 : « An interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose, adaptive study of the efficacy of KL1333 in adult patients with primary mitochondrial disease (PMD) », en cours de recrutement.
NCT04535609 : « A double-blind, placebo-controleld, study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrial myopathy », recrutement terminé.